Provence Wealth Management Group Biovie Inc. Transaction History

Provence Wealth Management Group

  • $186 Million
  • Q4 2023

A detailed history of Provence Wealth Management Group transactions in Biovie Inc. stock. As of the latest transaction made, Provence Wealth Management Group holds 550 shares of BIVI stock, worth $1,171. This represents 0.0% of its overall portfolio holdings.

Number of Shares
550
Previous 550 -0.0%
Holding current value
$1,171
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$2.75 - $5.17 $1,512 - $2,843
550 New
550 $1,000

Others Institutions Holding BIVI

# of Institutions
5
Shares Held
340K
Call Options Held
0
Put Options Held
0
View Full List

About BIOVIE INC.

BIVI Quotes by TradingView
  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $64.3M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Provence Wealth Management Group Portfolio

Follow Provence Wealth Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Provence Wealth Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Provence Wealth Management Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email